Literature DB >> 2452868

The accumulation mechanism of cationic mitomycin C-dextran conjugates in the liver: in-vivo cellular localization and in-vitro interaction with hepatocytes.

S Nakane1, S Matsumoto, Y Takakura, M Hashida, H Sezaki.   

Abstract

To elucidate the mechanism of the accumulation of mitomycin C-dextran conjugate (MMC-D) in the liver, in-vivo cellular uptake and in-vitro cellular interaction of MMC-D have been studied. Localization of cationic and anionic MMC-D (MMC-Dcat. and MMC-Dan.) in different liver cell types following i.v. administration was examined in rats and the significant contribution of parenchymal cells demonstrated. In-vitro cellular interaction was determined by measuring the drug concentration in the medium after incubation with rat isolated hepatocytes. MMC-Dcat. was highly adsorbed on the surface of hepatocytes at pH 7.2, while the interaction between MMC-Dan. and hepatocytes was negligible. The percentage association of MMC-Dcat. with hepatocytes remained almost constant during the course of incubation and no significant difference was observed between the incubation at 4 and 37 degrees C. The adsorption phenomenon was shown to conform to Langmuir's adsorption isotherm. The amount of MMC-Dcat. associated with hepatocytes increased as the molecular weight of the dextran chain increased. These results showed that MMC-Dcat. was adsorbed on the surface of hepatocytes by an electrostatic force and this binding was responsible for its remarkable accumulation in the liver in-vivo. Thus some physicochemical properties of the MMC-D conjugates are thought to play an important role in the disposition characteristics of the conjugates.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452868     DOI: 10.1111/j.2042-7158.1988.tb05139.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  8 in total

Review 1.  Drug delivery systems and liver targeting for the improved pharmacotherapy of the hepatitis B virus (HBV) infection.

Authors:  María L Cuestas; Verónica L Mathet; José R Oubiña; Alejandro Sosnik
Journal:  Pharm Res       Date:  2010-03-24       Impact factor: 4.200

2.  Hepatic disposition characteristics of electrically charged macromolecules in rat in vivo and in the perfused liver.

Authors:  K Nishida; K Mihara; T Takino; S Nakane; Y Takakura; M Hashida; H Sezaki
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

Review 3.  The Spectrum of Familial Hypercholesterolemia (FH) in Saudi Arabia: Prime Time for Patient FH Registry.

Authors:  Faisal Alallaf; Fatima Amanullah H Nazar; Majed Alnefaie; Adel Almaymuni; Omran Mohammed Rashidi; Khalid Alhabib; Fahad Alnouri; Mohamed-Nabil Alama; Mohammad Athar; Zuhier Awan
Journal:  Open Cardiovasc Med J       Date:  2017-07-26

4.  Disposition characteristics of macromolecules in tumor-bearing mice.

Authors:  Y Takakura; T Fujita; M Hashida; H Sezaki
Journal:  Pharm Res       Date:  1990-04       Impact factor: 4.200

5.  The structure of PEG-modified poly(ethylene imines) influences biodistribution and pharmacokinetics of their complexes with NF-kappaB decoy in mice.

Authors:  Klaus Kunath; Anke von Harpe; Holger Petersen; Dagmar Fischer; Karlheinz Voigt; Thomas Kissel; Ulrich Bickel
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

6.  The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake.

Authors:  K Kawabata; Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

7.  The Toxicokinetic Profile of Dex40-GTMAC3-a Novel Polysaccharide Candidate for Reversal of Unfractionated Heparin.

Authors:  Emilia Sokolowska; Bartlomiej Kalaska; Kamil Kaminski; Alicja Lewandowska; Agnieszka Blazejczyk; Joanna Wietrzyk; Irena Kasacka; Krzysztof Szczubialka; Dariusz Pawlak; Maria Nowakowska; Andrzej Mogielnicki
Journal:  Front Pharmacol       Date:  2016-03-17       Impact factor: 5.810

8.  Reversal Activity and Toxicity of Heparin-Binding Copolymer after Subcutaneous Administration of Enoxaparin in Mice.

Authors:  Justyna Swieton; Joanna Miklosz; Shin-Ichi Yusa; Krzysztof Szczubialka; Dariusz Pawlak; Andrzej Mogielnicki; Bartlomiej Kalaska
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.